Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuzhou Changfuxing Biomedical Technology is a biotechnology company based in Fuzhou, China, specializing in the research, development, and production of high-quality biological reagents and diagnostic raw materials. The company focuses on protein expression and purification, offering a wide range of recombinant proteins, cytokines, and antibodies for use in life science research and the development of diagnostic kits. Their technical expertise includes various expression systems such as E. coli, yeast, and mammalian cells. By providing essential tools for drug discovery and clinical diagnostics, the company supports the broader pharmaceutical and healthcare industries in China and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 福州长富星生物医药科技.